grant

Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation

Organization FRED HUTCHINSON CANCER CENTERLocation SEATTLE, UNITED STATESPosted 23 Aug 2016Deadline 31 May 2026
NIHUS FederalResearch GrantFY20252019 novel corona virus2019 novel coronavirus2019-nCoVAmericanBreakbone Fever VirusCOVID crisisCOVID epidemicCOVID pandemicCOVID-19 crisisCOVID-19 epidemicCOVID-19 eraCOVID-19 global health crisisCOVID-19 global pandemicCOVID-19 health crisisCOVID-19 pandemicCOVID-19 periodCOVID-19 public health crisisCOVID-19 virusCOVID-19 yearsCOVID19 virusCoV-2CoV2Communicable Disease Contact TracingCommunicable DiseasesContact TracingDENVDataData SetDengue VirusDengue fever virusDisease OutbreaksEBOVEarly DiagnosisEbolaEbola virusEbola-like VirusesEpidemicEpidemic Parotitis VirusEpidemiologic ResearchEpidemiologic StudiesEpidemiological StudiesEpidemiologistEpidemiologyEpidemiology ResearchEvolutionFutureGenesGeneticGenomicsGeographyGoalsGrippeHumanImmunityInfectious Disease Contact TracingInfectious DiseasesInfectious DisorderInfluenzaInfluenza VaccinesInfluenza VirusM tuberculosis infectionM. tb infectionM. tuberculosis infectionM.tb infectionM.tuberculosis infectionMTB infectionMethodologyMethodsModelingModern ManMonitorMumps virusMycobacterium tuberculosis (MTB) infectionMycobacterium tuberculosis infectionMyxovirus parotitidisOrthoebolavirusOutbreaksPatternPopulationPredispositionProcessPublic HealthSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV-2 epidemicSARS-CoV-2 global health crisisSARS-CoV-2 global pandemicSARS-CoV-2 pandemicSARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-coronavirus-2 epidemicSARS-coronavirus-2 pandemicSARS-related corona virus 2SARS-related coronavirus 2SARSCoV2Severe Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome CoV 2 epidemicSevere Acute Respiratory Syndrome CoV 2 pandemicSevere Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome coronavirus 2 epidemicSevere acute respiratory syndrome coronavirus 2 pandemicSevere acute respiratory syndrome related corona virus 2SusceptibilityTB infectionTimeTransmissionTuberculosisUnited StatesUpdateVaccinesVariantVariationViralViral BurdenViral GenomeViral LoadViral Load resultVirusWest AfricanWorkWuhan coronavirusZIKAZIKVZika Virusbio-informatics pipelinebioinformatics pipelinecoronavirus disease 2019 crisiscoronavirus disease 2019 epidemiccoronavirus disease 2019 global health crisiscoronavirus disease 2019 global pandemiccoronavirus disease 2019 health crisiscoronavirus disease 2019 pandemiccoronavirus disease 2019 public health crisiscoronavirus disease 2019 viruscoronavirus disease crisiscoronavirus disease epidemiccoronavirus disease pandemiccoronavirus disease-19 global pandemiccoronavirus disease-19 pandemiccoronavirus disease-19 virusdisseminated TBdisseminated tuberculosisearly detectionepidemiologicepidemiologic investigationepidemiologicalepidemiology studyflu vaccineflu virus vaccinegenomic datagenomic datasetgenomic epidemiologyhCoV19improvedinfection due to Mycobacterium tuberculosisinfluenza virus vaccineinfluenzavirusinnovateinnovationinnovativenCoV2noveloutbreak responsepandemicpandemic diseasepathogenpathogenic viruspublic health interventionseasonal fluseasonal influenzasevere acute respiratory syndrome coronavirus 2 global health crisissevere acute respiratory syndrome coronavirus 2 global pandemictooltransmission processtuberculosis infectiontuberculous spondyloarthropathyvaccine against fluvaccine against influenzavaccine efficacyviral disease outbreakviral genomicsviral outbreakviral pathogenvirus disease outbreakvirus genomevirus genomicsvirus pathogenweb sitewebsitezikav
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
Viral pathogens are an enduring threat to global public health. This project aims to use viral genomic data

to improve understanding of ongoing virus evolution and to make actionable inferences to reduce the global

burden of viral infectious disease. In order to be relevant for public health interventions, analyses of viral

sequence data need to be incredibly rapid, both in terms of computation and in terms of dissemination. To

accomplish these goals, this project will create novel methodological tools to analyze evolutionary dynamics

from influenza genetic sequence data and to analyze transmission patterns from outbreak sequence data.

Over the current project period (2016-2021), we developed a real-time analysis platform called Nextstrain,

which provides up-to-date analyses for a variety of pathogens including influenza virus, Ebola virus, Zika

virus, dengue virus, mumps virus, tuberculosis and SARS-CoV-2. Bioinformatic pipelines developed through

Nextstrain are reusable by academic groups and public health labs and resulting analyses are shareable via the

website nextstrain.org.

In the upcoming project period (2021-2026), we will refine methods for forecasting strain dynamics of influenza

virus. Monitoring and forecasting evolution of viral strains is of paramount importance. New antigenic variants

of influenza that partially escape from prior human immunity emerge and rapidly sweep through the viral

population. Such strains are less susceptible to vaccine-derived immunity and so antigenic evolution results in

the need to frequently update the seasonal influenza vaccine. This project aims to refine methods to forecast

strain dynamics and predict the makeup of the future influenza population. This forecasting is especially

relevant to influenza vaccine strain selection, as a vaccine strain is chosen for the Northern Hemisphere in

February for deployment the following winter. Accurate projections will aid in vaccine match for seasonal

influenza viruses and result in improved vaccine efficacy. Technical innovations focus on extending models to

work across different viruses, different gene segments and to incorporate spatial dynamics.

In an outbreak scenario such as the West African Ebola epidemic, the American Zika epidemic or the SARS-

CoV-2 pandemic, the focus of public health interventions focus on early diagnosis, contact tracing, isolation and

treatment. Epidemiological understanding of transmission dynamics is of paramount importance to outbreak

response. Viral genomic data can reveal otherwise hidden transmission patterns and aid in efficient contact

tracing. Geographic spread is especially amenable to genomic inferences. This project will develop tools to

make epidemiological inferences from outbreak sequence data. These methods will continue to be deployed

via the Nextstrain platform, allowing epidemiologists throughout the world to analyze their own datasets.

Genomic epidemiology has the potential to truly inform outbreak response. Nextstrain has been instrumental

to SARS-CoV-2 genomic epidemiology in the United States and world. Improvements to the accuracy and

capabilities of the platform would be well placed.

Grant Number: 5R35GM119774-11
NIH Institute/Center: NIH

Principal Investigator: Trevor Bedford

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →